Susquehanna International Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$5.38M Buy
2022
Q4
$694K Sell
2022
Q3
$2.38M Buy
2022
Q2
$357K Buy
2022
Q1
$434K Buy
2021
Q4
Hold